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ABSTRACT
Background Hospital Eye Services (HES) in the UK face 
an increasing number of optometric referrals driven by 
progress in retinal imaging. The National Health Service 
(NHS) published a 10-year strategy (NHS Long-Term 
Plan) to transform services to meet this challenge. In this 
study, we implemented a cloud-based referral platform 
to improve communication between optometrists and 
ophthalmologists.
Methods Retrospective cohort study conducted at 
Moorfields Eye Hospital, Croydon (NHS Foundation 
Trust, London, UK). Patients classified into the HES 
referral pathway by contributing optometrists have been 
included into this study. Main outcome measures was 
the reduction of unnecessary referrals.
Results After reviewing the patient’s data in a web-
based interface 54 (52%) out of 103 attending patients 
initially classified into the referral pathway did not need 
a specialist referral. Fourteen (14%) patients needing 
urgent treatment were identified. Usability was measured 
in duration for data input and reviewing which was 
an average of 9.2 min (median: 5.4; IQR: 3.4–8.7) for 
optometrists and 3.0 min (median: 3.0; IQR: 1.7–3.9) min 
for ophthalmologists. A variety of diagnosis was covered 
by this tool with dry age-related macular degeneration 
(n=34) being most common.
Conclusion After implementation more than half of 
the HES referrals have been avoided. This platform offers 
a digital-first solution that enables rapid-access eye 
care for patients in community optometrists, facilitates 
communication between healthcare providers and may 
serve as a foundation for implementation of artificial 
intelligence.
InTRoduCTIon
The prevalence of the most common retinal 
diseases, age-related macular degeneration (AMD) 
and diabetic retinopathy (DR), is rising in indus-
trialised countries. In addition to demographic 
changes, this trend is also partly driven by growing 
numbers of patients with diabetes mellitus.1–3 This 
is increasing the workload in hospital ophthalmic 
units, which in 2018/2019 had the highest number 
of outpatient attendances within the National 
Health Service (NHS) in the UK with 7.6 million 
patients annually.4 The service provision capacity 
is threatened by a low number of ophthalmologists 
per capita in the UK, which is further exacerbated 
by an expected growth of the population over 60 
years at twice the rate of the profession.5
People aged below 16 or above 60, with diabetes 
or a family history of glaucoma are eligible for a free 
eye test within the NHS every 2 years.6 The Opti-
cians Act 1989 obligates UK optometrists to refer 
any incidental eye abnormality detected during 
an NHS eye test to a Hospital Eye Services (HES) 
unless they provide a sufficient disease description 
including medical advice to the patient.7 With the 
introduction of advanced imaging devices as optical 
coherence tomography (OCT) and ultra-wide field 
imaging (UWFI), detection rates of asymptomatic 
retinal conditions and therefore specialist referrals 
have drastically increased.8
Cameron et al9 demonstrated that that more 
than a third of optometric referrals within the NHS 
did not need specialist consultancy.9 They also 
reported a reduction in these unnecessary refer-
rals following introduction of an electronic referral 
system containing images sent as email attachments. 
This accentuates the importance of communication 
between optometrists and HES within the NHS, 
especially addressing imaging data as reported by 
the British Broadcasting Corporation (BBC) in 
2016.10 Improved communication and data sharing 
could counteract the increasing pressure on HES by 
reducing unnecessary referrals.
The aim of this pilot study is to report the imple-
mentation and initial results of a cloud-based referral 
platform to medical retina HES, which was devel-
oped to overcome the increasing demand on scarce 
ophthalmologist services by improving communica-
tion between opticians and ophthalmologists.
MATeRIAl And MeThodS
Study setting and design
In this retrospective cohort study, data from a cloud-
based referral platform provided by Big Picture 
Medical (London, UK) was evaluated. All patients 
were referred to the medical retina service of Moor-
fields Eye Hospital, Croydon (NHS Foundation 
Trust, London, UK). This work was registered with 
the Service Improvement Department of Moor-
fields Eye Hospital and complies with the criteria 
defined in the Declaration of Helsinki. Before 
sharing data within the cloud, a mandatory consent 
for company policies and data processing was taken. 
An optional consent form for inclusion of de-iden-
tified clinical information including medical images 
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for the purposes of medical education, assessment and research 
was offered to all patients. Participating optometrists practised at 
six sites of Rawlings Opticians (Purley, Surrey, UK) spread over 
South-East England in Alresford, Caterham, Chandler’s Ford, 
Croydon, Purley and Winchester. Observation period spanned 
from April 2018 to January 2019. The rollout of the platform 
started in Rawlings Croydon Caterham and Winchester in early 
2018, followed by Chandler’s Ford, Purley and Winchester in 
July 2018.
data source
Each examination at the attending optician was performed 
by trained optometrists and comprised clinical data, an OCT 
scan (Nidek RS-3000 advance-2, Nidek, Tokyo, Japan) and a 
45° colour fundus photo centred on the macula. Clinical data 
included history of presenting complaint, best corrected visual 
acuity (BCVA) reported in Early Treatment Diabetic Retinop-
athy Study (ETDRS) letters and intraocular pressure. If visual 
acuity was quantified using a Snellen chart, ETDRS letters were 
extrapolated following an established method.11 After gaining 
informed consent, clinical and scan data were uploaded to the 
cloud-based referral software for further assessment by a consul-
tant ophthalmologist.
Participants
The participating optometrist were instructed to refer all presum-
ably retinal referrals via the platform. Initial triage took place 
by the optometrist and other referrals like glaucoma, cataract 
or anterior segment conditions were excluded and sent through 
the conventional general ophthalmic services (GOS) pathway 
defined by the NHS.12 Inclusion criteria of this study were as 
follows: all patients must have attended an eye examination at 
the contributing opticians; an optometrist must have assessed a 
patient and determined them to meet the criteria for a conven-
tional retinal HES referral; patients history, clinical findings and 
retinal imaging must have been taken and uploaded to the referral 
platform; referral refinement had to be carried out by a consul-
tant ophthalmologist. Patients were excluded from this study if 
relevant clinical information or imaging data were missing on 
the platform server. Moreover, patients had the option to opt for 
their depersonalised data to not be included in research and/or 
to be referred by the conventional GOS pathway.
Study outcomes
To assess the reduction in referrals achieved by this platform, 
the main study outcome was the result of the referral refinement 
carried out by a consultant ophthalmologist classified into:
 ► ‘Urgent referral’ (HES appointment ≤4 weeks): all causes of 
choroidal neovascularisation including age related macular 
degeneration and myopia, referable oedema as in diabetic 
maculopathy and subretinal fluid as in central serous 
chorioretinopathy.
 ► ‘Routine referral’ (HES appointment within 18 weeks 
referral to treatment time defined by the NHS13): all other 
non-urgent cases that needed further diagnostic or specialist 
evaluation and are not part of the category above.
 ► ‘No referral’ (yearly follow-up by optometrist): the absence 
of pathology classes described above.
The clinical outcome classified by the ophthalmologist was 
communicated to the partaking optometrist as well as to the 
patient by dual authentication electronic mail. The patient’s GP 
received a regular letter. Secondary outcome measures were the 
implementation of the cloud-based referral platform, patient 
characteristics, time to review and time spent with the software 
by optometrists and ophthalmologists.
Statistical methods
Data from the underlying cloud-based data-warehouse (Post-
greSQL, PostgreSQL Global Development Group) were exported 
to an Excel spreadsheet (Microsoft Corporation, Redmond, 
Washington, DC, USA) for statistical analyses. For all non-para-
metric data (eg, time to enter data) we reported values as mean, 
median, IQR and range. Conversely, for all normally distributed 
data (eg, age, BCVA) mean values are reported with SD.
ReSulTS
Implementation of a cloud-based referral platform
In May 2017, the cloud-based referral platform was initially 
introduced in three branches of Rawlings Opticians in the UK 
as an iPad app only. A web-based interface was launched in April 
2018 to improve ease of use and accessibility for the users and 
another three branches followed. For participating optometrists 
and ophthalmologists, the data upload interface and review 
centre are available through two different web links. Over the 10 
months observation period, 107 patients met inclusion criteria. 
These patients were examined by 11 qualified optometrists, who 
each used the platform to share data with a single consultant 
ophthalmologist from Moorfields Eye Hospital (DS). Four of 
the 107 patients were excluded as they had incomplete datasets 
caused by web browser-related data input issues. Accordingly 
to the time point of introduction of the referral platform and 
the size of the branch, most patients were examined at Rawl-
ings Croydon (n=60; 56%) followed by Chandlers-Ford (n=23; 
21%), Winchester (n=11; 10%), Purley (n=4; 4%), Alresford 
(n=3; 3%) and Caterham (n=2; 2%). In the same period, we 
counted in total 1.704 medical retina referrals to our hospital.
data input, processing and review
The Big Picture software enables optometrists to submit stan-
dardised clinical and retinal imaging data. Please note that all 
identifiable data provided in online supplemental figures 1 and 2 
are not an actual patient for our reference. Any resemblance to a 
real person living or deceased will be coincidence. When entering 
clinical history data, the user is met with questions and a range 
of mutually exclusive yet collectively exhaustive options to select 
from (online supplemental figure 1). Importantly, the set of ques-
tions that need to be addressed change depending on the patient 
presenting complaint to obtain a comprehensive, patient-centred 
clinical history. If a patient has previous scans stored within the 
OCT device, these are processed and uploaded as an imaging 
history together with the most recent scan. In the review centre, 
patients are allocated to the worklist of participating ophthal-
mologist for referral assessment. The review centre provides an 
overview of the patient’s clinical history and data as well as the 
related retinal images including OCT and colour fundus photog-
raphy (online supplemental figure 2). To complete the review, a 
clinical diagnosis and a referral decision must be given for each 
patient. Data are stored in regional UK servers provided by IBM 
(Armonk, New York, USA) to comply with national (NHS guid-
ance) and European (General Data Protection Regulation) data 
safety standards.14 15 A cloud-based data-warehouse using the 
open source PostgreSQL server reporting software stores and 
manages the clinical data. Imaging data from the devices can be 
processed in raw and Digital Imaging and Communications in 
Medicine formats.
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Table 1 Patient characteristics
Mean value±Sd (range)
Age 66.9±18.0 (23–95)
  Visual acuity right eye (ETDRS letters) 77.9±11.8 (0–89)
  Visual acuity left eye (ETDRS letters) 77.7±12.3 (0–89)
  Intraocular pressure right eye (mm Hg) 13.6±3.3 (7–24)
  Intraocular pressure left eye (mm Hg) 13.8±3.6 (7–25)
  Patients (n; %)
Sex   
  Female 55 (53)
  Male 47 (46)
  Unspecified 1 (1)
Ethnicity   
  African 4 (4)
  Caribbean 2 (2)
  Caucasian 92 (89)
  Indian 2 (2)
Other 3 (3)
ETDRS, Early Treatment Diabetic Retinopathy Study.
Table 2 Characteristics of presenting complaint
Patients (n; %)
Complaint laterality n=103
Both eyes 40 (39%)
Right eye 27 (26%)
Left eye 32 (31%)
None 4 (4%)
eye pain n=103
Present 1 (1%)
Absent 102 (99%)
Visual distortion n=103
Present 19 (18%)
Absent 81 (79%)
Unspecified 3 (3%)
Type of vision loss n=103
No vision loss 60 (58%)
Central vision loss 3 (3%)
Peripheral vision loss 1 (1%)
Distant objects vision loss 4 (4%)
Near objects vision loss 3 (3%)
General vision loss 32 (31%)
If vision loss present
Subjective severity of vision loss n=43
Mild 22 (51%)
Moderate 16 (37%)
Severe 5 (12%)
onset of visual complaint n=43
Quick 6 (14%)
Slow 36 (84%)
Unspecified 1 (2%)
Time measurements
The software measures the time spent for data input and 
reviewing, thereby enabling internal evaluation of software 
usability. The mean overall time for optometrists is 9.2 min 
(median: 5.4; IQR: 3.4–8.7) per patient, with 2.1 min (median: 
1.7; IQR: 1.1–2.4) spent on clinical history and 6.7 min (median: 
3.6; IQR: 2.1–5.7) on image acquisition. The mean review time 
for referral refinement by an ophthalmologist was 3.0 min in 
total (median: 3.0; IQR: 1.7–3.9), which consisted of 1.0 min 
(median: 0.3; IQR: 0.2–1.0), 1.1 min (median: 0.9; IQR: 
0.5–1.5) and 0.9 min (median: 0.8; IQR: 0.3–1.3) for entering 
clinical history, scans and writing the report. Average time until 
referral review by an ophthalmologist consultant was 6.4 days 
(median: 5.2; IQR: 2.9–8.0).
Patient characteristics
The mean age of the cohort (n=103) was 66.9±18.0 years (range: 
23–95). More than half of all patients were female (n=55; 53%) 
and of Caucasian ethnicity (n=92; 89%). At presentation, BCVA 
was 77.9±11.8 and 77.7±12.3 ETDRS letters for the right and 
left eye (range: 0–89), which equates to a mean Snellen fraction 
of 6/9. Further patient characteristics are summarised in table 1.
The most frequent presentations were unilateral (n=57; 
57%) and bilateral (n=40; 39%) visual deterioration. In cases 
reporting vision loss (n=43; 42% of all presentations), slow 
onset was more frequent than quick onset; and vision loss was 
described as mild in 22 (51%), moderate in 16 (37%) and severe 
in five (12%) patients. Only one patient reported ocular pain and 
visual distortion was reported by 19 patients (18%) (table 2).
Referral refinements by consultant ophthalmologist
More than half of the patients classified into the referral pathway 
by the optometrist did not require specialist referral (n=54; 
52%). In these cases, the outcome of ophthalmologist assessment 
was labelled ‘no referral necessary’, resulting in recommenda-
tion for annual follow-up at the optician. Fourteen patients 
(14%) were reviewed as urgent and 35 patients (34%) as routine 
referrals (figure 1). Vision loss was present in 86% of urgent 
referrals, whereas only 37% in the routine and no referral group 
reported this symptom. The most common diagnosis observed 
was dry AMD (n=34), followed by wet AMD (n=9), epiretinal 
membranes (n=7) and choroidal nevi (n=7). For seven patients, 
a diagnosis could not be made on clinical history and OCT scans 
alone (figure 2). Observing the distribution of diagnosis in the 
‘urgent referral’ group (n=14), the most common diagnosis 
was wet AMD (n=9), followed by other (n=3), central serous 
chorioretinopathy (CSCR) (n=1) and optic disc anomalies 
(n=1). For the ‘routine referrals’ (n=35) other (n=11) was the 
most common reason for referral, followed by dry AMD (n=6), 
ERM (n=6), unknown diagnose (n=3), choroidal naevus (n=2), 
CSCR (n=2), DR (n=2) optic disc anomalies (n=2) and glau-
coma (n=1).
dISCuSSIon
Main findings
In recognition of its current and impending pressures, the 
NHS published the Long-Term Plan in January 2019; a 10-year 
strategy of how the service will transform to meet this chal-
lenge.16 Herein, there is a call for digital solutions that effec-
tively facilitate communication between patients and healthcare 
professionals, as well as, between healthcare professionals of 
different disciplines that collectively coordinate care. The near 
ubiquity of internet access and internet devices among adults in 
Great Britain today (90% and 77%, respectively, in 2018) have 
made it possible to deliver positive clinical outcomes outlined 
in the Long-Term Plan.16 17 We report the development of such 
a tool—a cloud-based referral platform that expedites sharing 
of clinical and imaging data between optometrists and ophthal-
mologists. Not only general practitioner and ophthalmologist 
referrals, but also these from urgent care can be triaged into 
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Figure 1 Referral refinement by consultant ophthalmologist where 
each of the 103 cases were labelled as no referral, routine referral, or 
urgent referral.
Figure 2 Distribution of clinical diagnoses by consultant 
ophthalmologist.
the best suitable clinic setting (virtual or face to face clinics) 
(figure 3). Using the referral tool took optometrists on average 
9 min to gather and send pertinent clinical data of a single case 
to an ophthalmologist who took on average 3 min to review it. A 
reduction in the optometric referral rate of 54% was observed. 
As such, this platform yields time-efficient optometric referrals 
and reduces unnecessary ophthalmologist referrals within the 
NHS.
Telemedicine in the uK
Ophthalmology is ideally suited for service provision via telemed-
icine. A key reason for this is our ability to arrive at diagnoses 
and clinical decisions in an asynchronous fashion. For example, 
retinal disease classifications are increasingly reliant on OCT 
retinal imaging rather than on the more conventional binocular 
funduscopy.18 There are several proof-of-principle cases where 
hospital-based teleophthalmology services have been successfully 
implemented for various retinal conditions, including AMD, DR 
and retinopathy of prematurity.19 A major barrier in teleophthal-
mology has been overcome in the UK; namely, the high costs that 
accompany ophthalmic imaging equipment, such as retinal cameras 
and OCT devices.20 In 2017, the largest optical retail chain in 
the UK (Specsavers, Saint Andrew, UK), which has more than 
40% market share of optometry, announced the national rollout 
of OCT devices in all 740 practices.21 As all major competitors 
have followed this trend, the UK has the necessary retinal imaging 
infrastructure and posed to implement a cloud-based teleophthal-
mology platform as presented in this study.
unnecessary referrals have an impact on visual outcome
The unintended consequence of retinal imaging devices’ wide-
spread availability at high street opticians is the increased detec-
tion of asymptomatic retinal lesions that do not require medical 
intervention.8 With the referral policy defined in the,7 these 
asymptomatic findings become HES referrals and have contrib-
uted to the 37% false positive rate observed in optometric refer-
rals within the NHS.9 It is critical to address the high rate of 
unnecessary referrals as it negatively impacts patient outcomes 
by overburdening the clinical service and increasing the time for 
a patient to be seen and receive treatment. Indeed, it has been 
shown that patients with AMD can lose three lines of vision 
(ETDRS) if treatment is delayed by a mere 4 weeks.22 Similar 
results are reported in DR where belated detection increased 
the severity of pathological diabetic retinal changes.23 Digital 
communications platforms that identify urgent referrals with 
treatable conditions and prioritise them for timely treatment 
reduce the likelihood of vision loss.24 Our cloud-based referral 
platform enables this and identified 14% of our cohort as urgent 
referrals, which were treated accordingly in less than 4 weeks. 
All nine cases of wet AMD were correctly classified as urgent 
referrals. In addition to directing clinical services to individ-
uals requiring urgent medical intervention, the platform obvi-
ated 54% of referrals to HES. This is also of high importance 
in terms of limited available resources as the latest workforce 
census performed by the Royal College of Ophthalmology 
identified that two out of three HES’ rely on locums to offer 
needed patient care.25 Importantly this also provides a timely 
and deliverable method of communication between optome-
trists and ophthalmologists. This dialogue will not only promote 
improvement in diagnostic quality, but also provides continuous 
professional development for optometrists using this platform as 
a reassurance tool for themselves.
Patient centred care
With 43 patients (41.7%) AMD was the most common diagnosis 
made in our patient cohort. For patients with AMD in the UK, 
access to HES is highly dependent on geographical factors: up to 
50-fold variation in treatment frequency was observed in clus-
ters around specialist centres compared with rural areas.26 This 
implicates a struggle of access to HES for patients with retinal 
diseases living on the countryside. These patients carry an extra 
burden compared with the age and gender matched population 
without AMD. Along with the high age (more than half of the 
patients being above 75 years old) a majority is affected by visual 
impairment. Comorbidities are also more common than in the 
non-AMD population with 55% suffering from more than five 
potentially life-threatening diseases.27 This highlights the need 
of patient centred approaches to facilitate access to HES in 
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Figure 3 Primary care referrals can be triaged into virtual or face to face clinic settings under tertiary care. This decision is made by a specialist 
within the cloud-based referral platform and based on patient history and scans.
especially this highly vulnerable group of patients. Our telemed-
icine platform can be seen as a first step in simplifying access to 
specialist care. Clinical history and imaging data taken by the 
local optometrists can be accessed by specialists and the number 
of laborious visits can be avoided in these patients.
Strengths and limitations
The Big Picture cloud-based referral platform reduces unnec-
essary HES referrals in the NHS via a time-effective process 
mediated through a user-friendly interface. It took an average 
of 6.7 min (median of 3.6 min) to upload the scan data into the 
platform. Patient satisfaction and acceptability of healthcare 
interventions play a vital role in whether patients engage with 
novel services.28 Although this was not the scope of this study, 
we recognise that patient satisfaction is important and must be 
evaluated while upscaling telemedicine platforms within the 
NHS. Already available data suggests safety for virtual clinic 
settings for certain conditions.29 30 We are presently unable to 
report on the outcome of our ‘non-referral’ group yet, which 
is followed up by optometrists and future studies will evaluate 
patient safety in a teleophthalmology based referral platform. 
Another issue is the limitation of 45° colour fundus pictures to 
the posterior pole. Peripheral retinal changes as seen in UWFI 
might be missed. Independently of the clinic setting (virtual or 
consultant led medical retina clinic), the full spectrum of retinal 
imaging modalities is available.31
Future applications and economic impact
It has been shown that artificial intelligence can be used to 
develop algorithms that automatically detect retinal diseases, for 
example, AMD and DR.32 The first algorithm to classify severity 
of DR received Federal Drug Administration (FDA) approval in 
the USA in 2018.33 Tools for automatic OCT pattern recognition 
and referral decision-making have already been published and 
could be integrated into a cloud-based referral platform.34 This 
progress in medicine might simplify the widespread use of cloud-
based teleophthalmology platforms in the future.
With current tariffs for professional first attendance consulta-
tions ranging from £139 to £175 and nearly 8 million outpatient 
HES appointments yearly, we suspect a possible health economic 
impact of a cloud-based referral platform.4 35 A national rollout 
could reduce referrals to retinal HES and thereby cause direct 
cost savings to the NHS, even after factoring in technology and 
staffing costs. A separate study assessing the health economic 
impacts of the cloud-based telemedicine services in eye care is 
being planned.
ConCluSIon
In this study we report the first results of using a cloud-based 
referral platform within the UK and demonstrated that 54% 
of referrals to the HES could have been avoided. As the NHS 
faces increasing demand for service provision, innovations that 
enhance the digital maturity of secondary service healthcare 
professionals can further optimise the performance from limited 
resources.
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